ArticleDrug design, development and therapy2019

Baseline Lymphopenia: A Predictor Of Poor Outcomes In HER2 positive Metastatic Breast Cancer Treated With Trastuzumab.

Yi-Qun Che et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.